Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Electrophysiologically identified piriformis syndrome is successfully treated with incobotulinum toxin a and physical therapy.

Fishman LM, Wilkins AN, Rosner B.

Muscle Nerve. 2017 Aug;56(2):258-263. doi: 10.1002/mus.25504. Epub 2017 Apr 2.

PMID:
27935076
2.

Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study.

Fishman LM, Konnoth C, Rozner B.

Am J Phys Med Rehabil. 2004 Jan;83(1):42-50; quiz 51-3. Review.

PMID:
14709974
3.

BOTOX and physical therapy in the treatment of piriformis syndrome.

Fishman LM, Anderson C, Rosner B.

Am J Phys Med Rehabil. 2002 Dec;81(12):936-42.

PMID:
12447093
4.

Botulinum toxin type A use in piriformis muscle syndrome: a pilot study.

Childers MK, Wilson DJ, Gnatz SM, Conway RR, Sherman AK.

Am J Phys Med Rehabil. 2002 Oct;81(10):751-9.

PMID:
12362115
5.

Piriformis syndrome: diagnosis, treatment, and outcome--a 10-year study.

Fishman LM, Dombi GW, Michaelsen C, Ringel S, Rozbruch J, Rosner B, Weber C.

Arch Phys Med Rehabil. 2002 Mar;83(3):295-301. Review.

PMID:
11887107
6.

Long-Term Efficacy of Ultrasound-Guided Injection of IncobotulinumtoxinA in Piriformis Syndrome.

Rodríguez-Piñero M, Vidal Vargas V, Jiménez Sarmiento AS.

Pain Med. 2018 Feb 1;19(2):408-411. doi: 10.1093/pm/pnx135. No abstract available.

PMID:
28633454
7.

Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature.

Santamato A, Micello MF, Valeno G, Beatrice R, Cinone N, Baricich A, Picelli A, Panza F, Logroscino G, Fiore P, Ranieri M.

Toxins (Basel). 2015 Aug 10;7(8):3045-56. doi: 10.3390/toxins7083045. Review.

8.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

9.

Botulinum toxin type B in piriformis syndrome.

Lang AM.

Am J Phys Med Rehabil. 2004 Mar;83(3):198-202.

PMID:
15043354
10.

Piriformis muscle syndrome: diagnostic criteria and treatment of a monocentric series of 250 patients.

Michel F, Decavel P, Toussirot E, Tatu L, Aleton E, Monnier G, Garbuio P, Parratte B.

Ann Phys Rehabil Med. 2013 Jul;56(5):371-83. doi: 10.1016/j.rehab.2013.04.003. Epub 2013 Apr 25.

11.

Surgical Treatment of Piriformis Syndrome.

Han SK, Kim YS, Kim TH, Kang SH.

Clin Orthop Surg. 2017 Jun;9(2):136-144. doi: 10.4055/cios.2017.9.2.136. Epub 2017 May 8.

12.

An MRI evaluation of changes in piriformis muscle morphology induced by botulinum toxin injections in the treatment of piriformis syndrome.

Al-Al-Shaikh M, Michel F, Parratte B, Kastler B, Vidal C, Aubry S.

Diagn Interv Imaging. 2015 Jan;96(1):37-43. doi: 10.1016/j.diii.2014.02.015. Epub 2014 Apr 3.

13.
14.

Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.

Yoon SJ, Ho J, Kang HY, Lee SH, Kim KI, Shin WG, Oh JM.

Pharmacotherapy. 2007 May;27(5):657-65.

PMID:
17461700
15.

Evaluation of neural therapy effect in patients with piriformis syndrome.

Nazlıkul H, Ural FG, Öztürk GT, Öztürk ADT.

J Back Musculoskelet Rehabil. 2018;31(6):1105-1110. doi: 10.3233/BMR-170980.

PMID:
30010101
16.

Piriformis syndrome: long-term follow-up in patients treated with percutaneous injection of anesthetic and corticosteroid under CT guidance.

Masala S, Crusco S, Meschini A, Taglieri A, Calabria E, Simonetti G.

Cardiovasc Intervent Radiol. 2012 Apr;35(2):375-82. doi: 10.1007/s00270-011-0185-z. Epub 2011 May 24.

PMID:
21607823
17.

Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study.

Tassorelli C, De Icco R, Alfonsi E, Bartolo M, Serrao M, Avenali M, De Paoli I, Conte C, Pozzi NG, Bramanti P, Nappi G, Sandrini G.

Parkinsonism Relat Disord. 2014 Nov;20(11):1140-4. doi: 10.1016/j.parkreldis.2014.07.015. Epub 2014 Aug 13.

PMID:
25175601
18.

Piriformis syndrome: a cause of nondiscogenic sciatica.

Cass SP.

Curr Sports Med Rep. 2015 Jan;14(1):41-4. doi: 10.1249/JSR.0000000000000110. Review.

PMID:
25574881
19.

Computer-tomographic verification of ultrasound-guided piriformis muscle injection: a feasibility study.

Fabregat G, Roselló M, Asensio-Samper JM, Villaneuva-Pérez VL, Martínez-Sanjuan V, De Andrés J, Eichenberger U.

Pain Physician. 2014 Nov-Dec;17(6):507-13.

20.

Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.

Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG.

Obstet Gynecol. 2006 Oct;108(4):915-23.

PMID:
17012454

Supplemental Content

Support Center